from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3691/-

LFCtreatmentdescriptionclass of inhibitor

-0.820

Amikacinug/mL Amikacintranslation

-0.939

Cap5-10ug/mL Capreomycintranslation

-1.860

Rox10-50 ug/mL Roxithromycintranslation

-0.128

SM2-5 ug/mL Streptomycintranslation

-0.024

Tet5-10 ug/mL Tetracyclinetranslation

2.147

Rif0.2-5ug/mL Rifampicintranscription

0.881

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.003

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.491

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.698

CPZ10-50 ug/mL Chlorpromazinerespiration

0.801

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.229

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.900

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.108

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.256

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.578

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.710

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.990

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.785

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.028

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.026

KCN5-20 ug/mL Potassium cyaniderespiration

0.111

NaN30.2-2 mM Sodium aziderespiration

-0.345

Nigericin50 uM Nigericinrespiration

0.707

TRC10-150 ug/mL Triclosanrespiration

0.387

TRZ10-25 ug/mL Thioridazinerespiration

-2.809

Valinomycin0.5-10 uM Valinomycinrespiration

0.266

ZnSO42 mM ZnSO4respiration

-0.064

menadione6-10 ug/mL Menadionerespiration

0.740

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.073

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.016

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.407

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.782

NRP_1Non-replicating persistence stage 1dosRassociated

-0.149

Amp0.2mg/mL AmpicillincellWall

0.146

Cephalexin20-100 ug/mL CephalexincellWall

-0.384

Cerulenin0.32-5 ug/mL CerulenincellWall

0.392

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.888

EMB10-20 ug/mL EthambutolcellWall

0.256

Eta12-40 ug/mL EthionamidecellWall

0.272

INH0.2-0.4 ug/mL IsoniazidcellWall

0.041

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.530

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.035

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.517

BZA0.12 mg/mL BenzamidearomaticAmides

-0.442

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.636

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.156

H2O24 mM hydrogen peroxideDNAdamaging

0.217

Levo10 ug/mL LevofloxacinDNAdamaging

-0.943

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.267

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.541

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.542

UVUV-irradiationDNAdamaging

0.776

ARP41-4 ug/mL Antitubercular compound ARP4?

0.067

Antimycin12.5-50 ug/mL Antimycin A?

0.480

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.211

PA_110-50 ug/mL Antitubercular compound PA-1?

0.035

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.236

PA8240.2-2 ug/mL PA-824?

-0.130

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.460

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.079

Verapamil50 uM Verapamil?

0.112

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.632

methoxatin10-20 ug/mL Methoxatin?